These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 12687956)

  • 41. Hepatitis C virus infection among Thai blood donors: antibody prevalence, risk factors and development of risk screening form.
    Luksamijarulkul P; Thammata N; Sujirarat D; Tiloklurs M
    Southeast Asian J Trop Med Public Health; 2004 Mar; 35(1):147-54. PubMed ID: 15272759
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Access to care of patients with chronic hepatitis C virus infection in a university hospital: Is opioid dependence a limiting condition?
    Perut V; Labalette C; Sogni P; Ferrand I; Salmon-Céron D; Vidal-Trecan G
    Drug Alcohol Depend; 2009 Sep; 104(1-2):78-83. PubMed ID: 19464124
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hepatitis C in 6,865 patients 65 yr or older: a severe and neglected curable disease?
    Thabut D; Le Calvez S; Thibault V; Massard J; Munteanu M; Di Martino V; Ratziu V; Poynard T
    Am J Gastroenterol; 2006 Jun; 101(6):1260-7. PubMed ID: 16771947
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Risk factors for hepatitis C infection among sexually transmitted disease-infected, inner city obstetric patients.
    Choy Y; Gittens-Williams L; Apuzzio J; Skurnick J; Zollicoffer C; McGovern PG
    Infect Dis Obstet Gynecol; 2003; 11(4):191-8. PubMed ID: 15108864
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Twice-a-day versus once-a-day interferon-beta therapy in chronic hepatitis C.
    Kaito M; Yasui-Kawamura N; Iwasa M; Kobayashi Y; Nakagawa N; Fujita N; Ikoma J; Gabazza EC; Watanabe S; Adachi Y
    Hepatogastroenterology; 2003; 50(51):775-8. PubMed ID: 12828083
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Serological markers of autoimmunity in patients infected with hepatitis C virus: impact of HIV co-infection.
    Adeyemi OM; Attar B; Jensen D; Ghaoui R; Cotler SJ
    HIV Med; 2005 Nov; 6(6):371-4. PubMed ID: 16268816
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expert Consensus Conference. The screening for hepatitis C virus infection in adults in Italy, May 5-6, 2005.
    Writing Committee of the Consensus Panel
    Dig Liver Dis; 2006 Jul; 38(7):445-51. PubMed ID: 16735144
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The Hepatitis Network in Maine-et-Loire city hospitals: six year follow-up of patients and physicians. Hepatitis Network of Maine-et-Loire].
    Fouchard-Hubert I; Tréchot JF; Geagea E; Payan C; Rabjeau J; Calès P
    Gastroenterol Clin Biol; 2000 Jan; 24(1):82-8. PubMed ID: 10679589
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Recent advances in hepatitis C.
    Cecil B; Lavelle M
    J Ky Med Assoc; 2000 Oct; 98(10):440-4. PubMed ID: 11059215
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Risk factors of hepatitis C virus contamination among patients admitted at the Emergency Service of the Picardie Hospitals. Role of screening carried out according to the recommendations of the General Direction of Health].
    Capron D; Bensousan T; Darchis JP; Barbare JC; Butel J; Bental A; Cadranel JF; Goll A; Levy P; Ink O; Autret P; Bouraya D; Thiébaut JM; Moucheron JJ; Bernard M; Lallement PY; Delobel P
    Gastroenterol Clin Biol; 1998; 22(6-7):646-7. PubMed ID: 9762338
    [No Abstract]   [Full Text] [Related]  

  • 51. [Organized hepatitis C screening. Results and cost of a one-year campaign in a pilot area].
    Monnet E; Mercet P; Woronoff-Lemsi MC; Bresson-Hadni S; Pruniaux J; Cottray P; Bouiller C; Allemand H; Miguet JP
    Gastroenterol Clin Biol; 2000 May; 24(5):541-6. PubMed ID: 10891743
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Hepatitis C].
    López Torres A
    Rev Gastroenterol Peru; 1992; 12(3):163-5. PubMed ID: 1340249
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Experience at the Val de Marne/Essonne network].
    Bastie A
    Soins; 1999 Dec; (641):41-3. PubMed ID: 10857438
    [No Abstract]   [Full Text] [Related]  

  • 54. [The management of patients who test positive for hepatitis C in a free and anonymous testing centre is critical for follow-up].
    Aparicio T; Zouari L; Abramowitz L; Aumaitre H; Bonnaud G; Branger M; Leger P; Soulé JC; Crémieux AC
    Gastroenterol Clin Biol; 2002 May; 26(5):539-41. PubMed ID: 12122374
    [No Abstract]   [Full Text] [Related]  

  • 55. Screening for hepatitis C virus infection in India.
    Anand AC; Dhot PS; Ohri VC
    J Assoc Physicians India; 1998 Jul; 46(7):667-8. PubMed ID: 12152864
    [No Abstract]   [Full Text] [Related]  

  • 56. [Hepatitis C screening in an anonymous and free screening center in Rouen].
    Roque I; Goria O; Merle V; Bord S; Janvresse C; Czernichow P; Colin R
    Gastroenterol Clin Biol; 1999 Dec; 23(12):1397-8. PubMed ID: 10642626
    [No Abstract]   [Full Text] [Related]  

  • 57. Hepatitis C. Past, present and future issues.
    King RR
    Adv Nurse Pract; 1997 Mar; 5(3):51-2, 55-6. PubMed ID: 9459882
    [No Abstract]   [Full Text] [Related]  

  • 58. Improving identification and awareness of hepatitis C.
    Hainsworth T
    Nurs Times; 2005 Oct 18-24; 101(42):23-4. PubMed ID: 16259193
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Natural history of hepatitis C infection: a concise review.
    Lim JK
    Yale J Biol Med; 2001; 74(4):229-37. PubMed ID: 11697481
    [No Abstract]   [Full Text] [Related]  

  • 60. [Consensus Conference. Hepatitis C: screening and treatment. Paris, 16-17 January. Cité des Sciences et de l'Industrie--La Villette--Paris].
    Ann Chir; 1997; 51(3):212-6. PubMed ID: 9297881
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.